Clinical Trials

Showing 41 - 60 of 495 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096]
Trippett, Tanya
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-210]
Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
Relapsed/Refractory
[Protocol 13-021]
Trippett, Tanya
  • Pediatric Brain Tumors
    • CNS Cancer
  • Primary Bone
  • Sarcomas
  • Solid Tumors
A Phase II Study of Exemestane with and without Enzalutamide in Women with Advanced Hormone Receptor-Positive Breast Cancer
[Protocol 13-257]
Traina, Tiffany
  • Breast Cancer
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Enzalutamide in Women with Triple-Negative Breast Cancer that Contains the Androgen Receptor
[Protocol 13-158]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany
  • Breast Cancer
Prospective Ascertainment for Late Effects Among Cancer Survivors
[Protocol 12-143]
Tonorezos, Emily
  • Survivorship
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164]
Tew, William
  • Geriatrics
  • Ovarian Cancer
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
[Protocol 12-089]
Tew, William
  • Breast Cancer
  • Geriatrics
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
[Protocol 12-104]
Tew, William
  • Geriatrics
  • Ovarian Cancer
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
  • Thyroid Cancer
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
[Protocol 13-192]
Tamari, Roni
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181]
Tallman, Martin
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Myeloproliferative Neoplasm
A Phase III Study of Clofarabine versus Standard Therapy for Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Newly Diagnosed
[Protocol 12-059]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Study Comparing Whole Breast Screening Ultrasound with 3D Mammography (Digital Breast Tomosynthesis) in Women Scheduled for Digital Mammography and Ultrasound
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-119]
Sung, Janice
  • Breast Cancer
A Phase II Study of the MatriStem Surgical Matrix to Reinforce the Esophagus in Patients Having Surgery for Gastric and Esophageal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-178]
Strong, Vivian
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Randomized Phase III Study of Standard Chemotherapy with and without Brentuximab in Patients Newly Diagnosed with Advanced Hodgkin Lymphoma
[Protocol 13-056]
Straus, David
  • Lymphoma
    • Hodgkin's Disease